您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Anticoagulant Drugs Market Report

健康网讯：

Market Research Report on Chinese Blood Thinning Drugs

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$2,400 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Directory
1 Summary
2 Different categories of blood thinning drugs
  2.1 Anticoagulant Drugs
  2.2 Antiplatelet drugs
  2.3 Others of Anticoagulant or Antiplatelet drugs
  2.4 Thrombolysis drugs
3 Sales analysis of blood thinning drugs in the past 4 years
  3.1 Market scale and growth trend
  3.2 Market share and change trend
    3.2.1 Sales shares of different products of Blood Thinning Drugs
    3.2.2 Sales shares of different products of Antiplatelet drugs
    3.2.3  Sales shares of different products of Anticoagulant Drugs
    3.2.4 Sales shares of different products of Thrombolysis drugs
  3.3 Change about sales rank of key brands
4 Market analysis of blood thinning drugs last year
  4.1 Sales shares of different products
  4.2 Sales shares of different brands
  4.3 Key products and competitive enterprises of Antiplatelet drugs
      Clopidogrel
      Ozagrel sodium
      Aspirin
      Cilostazol
      Ticlopidine
      Tirofiban
  4.4 Key products and competitive enterprises of Antiplatelet drugs
      Low molecular weight heparin sodium
      Low molecular weight heparin calium
      Heparn sodium
      Warfarin sodium
      Heparn calium
      Sodium Citrate
5 Sales analysi of key cities
6 Research and development in China
  6.1 List of Domestic marketd products and import procucts
  6.2 Status of application and approval for Blood Thinning Drugs